Influence of Serum Sodium Levels on Bone Metabolism and Turnover in Hospitalized Patients

NCT04227301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2025-05-29

No results posted yet for this study

Summary

In this study, the possible role of serum sodium concentration and its changes on bone markers in hospitalized, hyponatremic patients is determined. Therefore, it is investigated whether in hospitalized, hyponatremic patients the level of carboxy-terminal collagen crosslinks (CTX) is modified by changes in plasma sodium concentration, independently from the aetiology of hyponatremia.

Conditions

Interventions

OTHER

blood sampling

blood sampling for measurement of bone markers after a fasting period of at least 6 hours

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof. Dr. med · Endocrinology, Diabetology and Metabolism, University Hospital Basel

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-13
Primary Completion
2025-02-24
Completion
2025-02-24

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04227301 on ClinicalTrials.gov